Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Jones

Showing results (241-250 of 278) with videos related to

Pageof 28
Sort By:
Leukemia & Lymphoma|May 3, 2008
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative studyRaymond Lai, Nancy L Bartlett, John R Mackey, et al.
Open Heart|April 21, 2021
Reintroduction of elective cardiac interventions in the era of COVID-19: the Barts experienceStephen Hamshere, Katrina Comer, Fizzah Choudhry, et al.
Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.
Journal of Hematology & Oncology|January 5, 2025
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphomaSayan Mullick Chowdhury, Subodh Bhatta, Timothy J Voorhees, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2025
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancerDan Jones, Abu Nasar, Jonathan Villena-Vargas, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2025
Minimally invasive resection of non-small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitalsPeter J Kneuertz, Nestor Villamizar, Nasser K Altorki, et al.
Cytotherapy|August 26, 2010
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft modelQing Ma, Changqing Wang, Dan Jones, et al.
Blood|May 15, 2010
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemiaFarhad Ravandi, Susan O'Brien, Deborah Thomas, et al.
American Journal of Clinical Pathology|May 25, 2025
Endoscopic ultrasound-guided pancreatic core-needle/microforceps biopsy is a valuable diagnostic tool for pancreatic lesions: Experience from a large academic institutionSaba Shafi, Wendy L Frankel, Zaibo Li, et al.
British Journal of Haematology|January 20, 2007
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphomaNam H Dang, Barbara Pro, Fredrick B Hagemeister, et al.
Pageof 28

Showing results (241-250 of 278) with videos related to

Sort By:
Pageof 28
Leukemia & Lymphoma|May 3, 2008
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative studyRaymond Lai, Nancy L Bartlett, John R Mackey, et al.
Open Heart|April 21, 2021
Reintroduction of elective cardiac interventions in the era of COVID-19: the Barts experienceStephen Hamshere, Katrina Comer, Fizzah Choudhry, et al.
Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.
Journal of Hematology & Oncology|January 5, 2025
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphomaSayan Mullick Chowdhury, Subodh Bhatta, Timothy J Voorhees, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2025
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancerDan Jones, Abu Nasar, Jonathan Villena-Vargas, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2025
Minimally invasive resection of non-small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitalsPeter J Kneuertz, Nestor Villamizar, Nasser K Altorki, et al.
Cytotherapy|August 26, 2010
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft modelQing Ma, Changqing Wang, Dan Jones, et al.
Blood|May 15, 2010
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemiaFarhad Ravandi, Susan O'Brien, Deborah Thomas, et al.
American Journal of Clinical Pathology|May 25, 2025
Endoscopic ultrasound-guided pancreatic core-needle/microforceps biopsy is a valuable diagnostic tool for pancreatic lesions: Experience from a large academic institutionSaba Shafi, Wendy L Frankel, Zaibo Li, et al.
British Journal of Haematology|January 20, 2007
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphomaNam H Dang, Barbara Pro, Fredrick B Hagemeister, et al.
Pageof 28